The efficacy of bortezomib during induction therapy in patients with high-risk acute lymphoblastic leukemia

The efficacy of bortezomib during induction therapy in patients with high-risk acute lymphoblastic leukemia

Introduction: Acute lymphoblastic leukemia (ALL) is characterized by the uncontrolled proliferation of lymphoid precursor cells, most from the B phenotype, which is the result of various cytogenetic mutations and alterations involved in cell division and survival. Objective: To evaluate the efficacy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Camila Terreros-Palacios, Daniela Pérez-Sámano, Adán G. Gallardo-Rodríguez, Irma Olarte-Carrillo, Carlos Martínez-Murillo, Gilberto I. Barranco-Lampon, Christian Ramos-Peñafiel
Format:	Article
Language:	English
Published:	Permanyer 2025-07-01
Series:	Revista Médica del Hospital General de México
Subjects:	Acute lymphoblastic leukemia. Bortezomib. Measurable residual disease. Complete remission. Overall survival.
Online Access:	https://www.hospitalgeneral.mx/frame_eng.php?id=260
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
by: NA Batmanova, et al.
Published: (2017-07-01)

Bortezomib (Velcade) in combination with dexamethasone eor relapsed or refractory myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Bortezomib (velcade) plus melphalan and prednisone in elderly untreated patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Modern strategies in therapy of elderly patients with multiple myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Efficacy and safety of blinatumomab in Chinese patients with relapsed/refractory B-cell acute lymphoblastic leukemia: a single-center retrospective study
by: Yan Wang, et al.
Published: (2025-05-01)

Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT
by: Ryszard Swoboda, et al.
Published: (2025-04-01)

Effect of <i>ABCB1</i> Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia
by: Christian Omar Ramos Peñafiel, et al.
Published: (2025-02-01)

Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
by: Juan M. Cano-Calderón, et al.
Published: (2025-01-01)

Hepatic Dysfunction during Induction Chemotherapy in Children with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma and Its Effects on Subsequent Therapy and Outcome
by: Nalla Anuraag Reddy, et al.
Published: (2024-04-01)

High-dose versus Standard-dose Daunorubicin in Induction Chemotherapy for Acute Myeloid Leukemia: A Meta-Analysis
by: Bibi Kulsoom, et al.
Published: (2025-06-01)

Surveillance and expected outcome of acute lymphoblastic leukemia in children and adolescents: An experience from Eastern India
by: Ashis Mukhopadhyay, et al.
Published: (2013-01-01)

The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study
by: Fei Xin, et al.
Published: (2024-12-01)

First pediatric B-acute lymphoblastic leukemia patient treated with anti-CD19 chimeric antigen receptor T-cell therapy: Long-term remission or early cure?
by: Dimitrios Bouzianas, et al.
Published: (2024-12-01)

Alemtuzumab in treatment of chronic lymphocytic leukemia
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Infant lymphoblastic leukemia: a single centers 10 year experience
by: İnci Yaman-Bajin, et al.
Published: (2019-06-01)

Visual-motor function disorders in children who survived acute lymphoblastic leukemia and central nervous system tumors
by: A. A. Deviaterikova
Published: (2025-03-01)

Hemostasis defects correction in children with acute lymphoblastic leukemia
by: A. S. Roshik, et al.
Published: (2022-11-01)

Radiation-induced hypopituitarism in children with acute lymphoblastic leukemia
by: Mehrdad Mirouliaei, et al.
Published: (2013-01-01)

Features of children temperament with acute lymphoblastic leukemia
by: N. A. Kornetov, et al.
Published: (2016-02-01)

Immunophenotypic investigation of infant acute lymphoblastic leukemia
by: A. M. Popov, et al.
Published: (2014-07-01)

Does distance to the hospital affect the course of treatment and follow-up for children with Acute Lymphoblastic Leukemia?
by: Cecilie Bjerregaard Brix, et al.
Published: (2025-02-01)

Combination of venetoclax with CHG regimen in refractory/relapsed T-lymphoblastic lymphoma/acute lymphoblastic leukemia: a case series and literature review
by: Mei Zhou, et al.
Published: (2025-07-01)

SLC19A1 polymorphism and serum methotrexate in patients with acute lymphoblastic leukemia
by: Beuy Joob, et al.
Published: (2018-01-01)

Acute lymphoblastic leukemia presenting as nephromegaly in a child: A rare case report
by: Shilpa Khanna Arora, et al.
Published: (2019-02-01)

Results of multiple myeloma treatment with bortezomib
by: T. I. Pospelova, et al.
Published: (2022-11-01)

Thiopurine methyltransferase polymorphisms in children with acute lymphoblastic leukemia
by: Vijay Gandhi Linga, et al.
Published: (2014-01-01)

HETEROGENEITY OF CHILDHOOD B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (EGIL SUBTYPE BIV)
by: I. A. Demina, et al.
Published: (2018-02-01)

Secondary neoplasms in survivors of pediatric acute lymphoblastic leukemia and lymphoblastic lymphoma: a single-center, retrospective study
by: Eri Ushida, et al.
Published: (2025-01-01)

Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol
by: Venkatraman Radhakrishnan, et al.
Published: (2015-01-01)

Histiocytic sarcoma with acute lymphoblastic leukemia a rare association- Case report and literature review
by: ABHIJEET PRAKASH GANAPULE, et al.
Published: (2014-08-01)

Catch-22 Situation with Unexpected Reports in Acute Lymphoblastic Leukemia
by: Swetha Palla, et al.
Published: (2025-04-01)

Bortezomib neurotoxicity treatment of multiple myeloma: single center experience and literature review
by: N. V. Stepanova, et al.
Published: (2022-11-01)

Understanding Patients’ Experiences in Newly Diagnosed Adult B Cell Acute Lymphoblastic Leukemia: Qualitative Interviews to Develop a Patient-Centric Conceptual Model
by: Michael Chladek, et al.
Published: (2025-04-01)

The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
by: Xiaoxia Wu, et al.
Published: (2024-09-01)

Correlation of Baseline Clinical Characteristics as Risk Factors for Pneumonia in Children with Acute Lymphoblastic Leukemia (ALL)
by: Prachi Singh, et al.
Published: (2025-03-01)

Study of Some Biochemical Parameters in Iraqi Children with Acute Lymphoblastic Leukemia
by: Baghdad Science Journal
Published: (2015-06-01)

Profile of acute lymphoblastic leukemia in children under 2 years of age
by: Anoop Cherungonath, et al.
Published: (2018-01-01)

Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial
by: SN Bondarenko, et al.
Published: (2019-03-01)

Cerebral aspergillus infection in pediatric acute lymphoblastic leukemia induction therapy
by: Gaurav Prakash, et al.
Published: (2012-01-01)

COVID-19 in patients with acute lymphoblastic leukemia
by: T. S. Chudnova, et al.
Published: (2024-09-01)